1. India Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - General
Pfizer Limited

Pfizer Limited

PFIZER.NS
Pfizer LimitedIN flagNational Stock Exchange of India
4,493.50
INR
-9.60
- -
205.57BMarket Cap

Total Valuation

Pfizer Limited carries a market capitalization of 205.57B, placing it among publicly traded companies globally. Its enterprise value stands at 185.51B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap205.57B
Enterprise Value185.51B

Share Statistics

Pfizer Limited currently has 45.75M shares outstanding.

Shares Outstanding45.75M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Pfizer Limited trades at a trailing price-to-earnings ratio of 29.89. The price-to-sales ratio is 8.57, and the price-to-book ratio stands at 472.01.

PE Ratio29.89
PS Ratio8.57
PB Ratio472.01
P/TBV Ratio5.90
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Pfizer Limited trades at an EV/EBITDA multiple of 21.92 and an EV/FCF ratio of 2,642.81. The EV/Sales ratio of 7.36 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 21.92 provides insight into valuation relative to core operating earnings.

EV / Sales7.36
EV / EBITDA21.92
EV / EBIT21.92
EV / FCF2,642.81

Financial Position

Pfizer Limited maintains a current ratio of 6.06, meaning it holds 6.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.67, indicating elevated leverage, while an interest coverage ratio of 89.28 demonstrates strong ability to service its debt obligations.

Current Ratio6.06
Quick Ratio4.96
Debt / Equity1.67
Debt / EBITDA0.08
Interest Coverage89.28

Financial Efficiency

Pfizer Limited posts a return on equity of 57.17 and a return on invested capital of 13.89.

Return on Equity (ROE)57.17
Return on Assets (ROA)14.69
Return on Invested Capital (ROIC)13.89
Return on Capital Employed (ROCE)53.91
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.86

Taxes

Over the trailing twelve months, Pfizer Limited has paid 2.53B in income taxes, reflecting an effective tax rate of 25.96.

Income Tax2.53B
Effective Tax Rate25.96

Stock Price Statistics

Pfizer Limited's stock has declined approximately -23.32565% over the past 52 weeks. The 50-day moving average sits at 4,705.46, while the 200-day moving average is 4,908.36.

Beta (5Y)N/A
52-Week Price Change-23.32565%
50-Day Moving Average4,705.46
200-Day Moving Average4,908.36
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Pfizer Limited generated 25.20B in revenue and converted that into 7.22B in net income, yielding earnings per share of 157.92. EBITDA reached 8.46B, while operating income came in at 8.46B.

Revenue25.20B
Gross Profit16.35B
Operating Income8.46B
Pretax Income9.76B
Net Income7.22B
EBITDA8.46B
EBIT8.46B
Earnings Per Share (EPS)157.92

Balance Sheet

Pfizer Limited holds 31.14B in cash and equivalents against 702.30M in total debt, resulting in a net debt position of -1.00B. Total book value stands at 457.50M, with working capital of 31.76B providing operational flexibility.

Cash & Cash Equivalents31.14B
Total Debt702.30M
Net Debt-1.00B
Equity (Book Value)457.50M
Book Value Per Share10.00
Working Capital31.76B

Margins

Pfizer Limited operates with a gross margin of 64.90, reflecting its pricing power and cost economics. The operating margin of 33.59 and net profit margin of 28.67 provide insight into operational efficiency.

Gross Margin64.90
Operating Margin33.59
Pretax Margin38.72
Profit Margin28.67
EBITDA Margin33.59

Stock Splits

Pfizer Limited's most recent stock split took place on June 12, 2000 with a 1:2 split ratio.

Last Split Date6/12/2000
Split Ratio1:2

Scores

Pfizer Limited posts an Altman Z-Score of 20.10, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score20.10